Artivion AORT Preservation services — Perclot revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Artivion in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artivion's preservation services — perclot revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artivion's preservation services — perclot revenues?
- Artivion (AORT) reported preservation services — perclot revenues of $24.9M in Q1 2026.
- How has Artivion's preservation services — perclot revenues changed year-over-year?
- Artivion's preservation services — perclot revenues increased by 23.4% year-over-year, from $20.18M to $24.9M.
- What is the long-term trend for Artivion's preservation services — perclot revenues?
- Over 4 years (2021 to 2025), Artivion's preservation services — perclot revenues has grown at a 5.5% compound annual growth rate (CAGR), from $77.24M to $95.51M.
- What does preservation services — perclot revenues mean?
- This metric tracks the total revenue generated specifically from the sale of Perclot, a surgical hemostatic agent, within the preservation services business segment. It measures the market adoption and commercial performance of this specific product line. Monitoring these revenues helps investors assess the growth trajectory and competitive positioning of the company's surgical adhesive portfolio.